E-LIB Suche - Ergebnisse für: Goldman, W.

1

214TiP Tarlatamab after chemoradiotherapy in limited-stage ..:

Hummel, H-D. ; Paz-Ares, L. ; Blackhall, F....
ESMO Open. 9 (2024) - p. 102787 , 2024

Link: https://doi.org/10.1016/..

2

OA01.09 Adjuvant Osimertinib in Resected EGFR-Mutated Stage..:

Herbst, R.S. ; Wu, Y.-L. ; Grohe, C....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e4 , 2023

Link: https://doi.org/10.1016/..

3

EE192 The Relationship between Systematic Lupus Erythematos..:

Levy, J. ; Alemao, E. ; Sbarigia, U...
Value in Health. 26 (2023) 6 - p. S94 , 2023

Link: https://doi.org/10.1016/..

4

OA21.04 Amivantamab in Patients with Advanced NSCLC and MET..:

Leighl, N. ; Cho, B.C. ; Hiret, S....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S93-S94 , 2023

Link: https://doi.org/10.1016/..

5

Durvalumab, with or without tremelimumab, plus platinum-eto..:

Paz-Ares, L. ; Chen, Y. ; Reinmuth, N....
ESMO Open. 7 (2022) 2 - p. 100408 , 2022

Link: https://doi.org/10.1016/..

6

Improved EGFR mutation detection using combined exosomal RN..:

Krug, A.K. ; Enderle, D. ; Karlovich, C....
Annals of Oncology. 29 (2018) 3 - p. 700-706 , 2018

Link: https://doi.org/10.1093/..

7

Interim results from the phase I study of nivolumab (nivo) ..:

Wainberg, Z.A. ; George, B. ; Goldman, J.W....
European Journal of Cancer. 69 (2016) - p. S103 , 2016

Link: https://doi.org/10.1016/..

8

3104 Rociletinib treatment and outcomes in non-small cell l..:

Solomon, B. ; Wakelee, H. ; Sequist, L.V....
European Journal of Cancer. 51 (2015) - p. S636 , 2015

Link: https://doi.org/10.1016/..

9

3105 Dose optimization of rociletinib for EGFR mutated NSCL..:

Soria, J.C. ; Goldman, J.W. ; Wakelee, H....
European Journal of Cancer. 51 (2015) - p. S637 , 2015

Link: https://doi.org/10.1016/..

10

3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-s..:

Gadgeel, S. ; Soria, J.C. ; Goldman, J.W....
European Journal of Cancer. 51 (2015) - p. S628 , 2015

Link: https://doi.org/10.1016/..

11

3009 Activity of rociletinib in EGFR mutant NSCLC patients ..:

Varga, A. ; Camidge, D.R. ; Sequist, L.V....
European Journal of Cancer. 51 (2015) - p. S598 , 2015

Link: https://doi.org/10.1016/..

12

Safety and Clinical Activity of MK-3475 as Initial Therapy ..:

Balmanoukian, A.S. ; Rizvi, N.A. ; Garon, E.B....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S1-S2 , 2014

Link: https://doi.org/10.1016/..

13

10LBA Interim phase 2 results of study CO-1686-008: A phase..:

Soria, J. ; Sequist, L.V. ; Goldman, J.W....
European Journal of Cancer. 50 (2014) - p. 199 , 2014

Link: https://doi.org/10.1016/..

14

498 CDK4/6 inhibitor (LY2835219) exhibits potent anti-tumor..:

Goldman, J.W. ; Garon, E.B. ; Conklin, D....
European Journal of Cancer. 50 (2014) - p. 162 , 2014

Link: https://doi.org/10.1016/..

15

Learning Chronobiology by Improving Wikipedia:

Chiang, C.D. ; Lewis, C.L. ; Wright, M.D.E....
Journal of Biological Rhythms. 27 (2012) 4 - p. 333-336 , 2012

Link: https://doi.org/10.1177/..